Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 80%
Negative

Neutral
Business Wire
yesterday
Owlet Earns Spot on Fast Company's 2025 Brands That Matter List
LEHI, Utah--(BUSINESS WIRE)---- $owlt #FCBrandAwards--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, is proud to announce its inclusion in Fast Company's annual Brands That Matter list. This recognition celebrates brands that create deep emotional connection and cultural relevance, not just customer acquisition, through clear purpose, originality, and measurable business impact. “We're honored to be recognized by Fast Company as a brand that truly matters,” said Jonathan Ha.
Owlet Earns Spot on Fast Company's 2025 Brands That Matter List
Positive
Zacks Investment Research
12 days ago
What Makes Owlet (OWLT) a New Strong Buy Stock
Owlet (OWLT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
What Makes Owlet (OWLT) a New Strong Buy Stock
Neutral
Business Wire
14 days ago
Owlet and Locus Health Partner to Seamlessly Deliver Infant Health Data into Remote Patient Monitoring Programs
LEHI, Utah--(BUSINESS WIRE)---- $owlt #babymonitor--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announces a partnership with Locus Health, a leader in remote patient monitoring, for more integrated infant health management. The collaboration connects data from Owlet's FDA-cleared prescription device, BabySat®, directly into the Locus Health platform, giving healthcare providers ongoing and secure access to vital infant health information after hospital discharge.
Owlet and Locus Health Partner to Seamlessly Deliver Infant Health Data into Remote Patient Monitoring Programs
Neutral
Seeking Alpha
19 days ago
Owlet, Inc. (OWLT) Q3 2025 Earnings Call Transcript
Owlet, Inc. ( OWLT ) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants Jay Gentzkow - Vice President of Investor Relations Jonathan Harris - CEO & President Amanda Crawford - Chief Financial Officer Conference Call Participants Lucas Romanski - TD Cowen, Research Division Owen Rickert - Northland Capital Markets, Research Division Presentation Operator Good afternoon. Thank you for attending the Owlet Q3 '25 Earnings Conference Call.
Owlet, Inc. (OWLT) Q3 2025 Earnings Call Transcript
Positive
Zacks Investment Research
19 days ago
Owlet, Inc. (OWLT) Surpasses Q3 Earnings and Revenue Estimates
Owlet, Inc. (OWLT) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of a loss of $0.23 per share. This compares to earnings of $0.03 per share a year ago.
Owlet, Inc. (OWLT) Surpasses Q3 Earnings and Revenue Estimates
Neutral
Business Wire
19 days ago
Owlet Reports Third Quarter 2025 Financial Results
LEHI, Utah--(BUSINESS WIRE)---- $owlt #babymonitor--Owlet, Inc. (“Owlet” or the “Company”) (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the third quarter ended September 30, 2025. Owlet's Chief Executive Officer and President, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business and corporate update today, November 13, 2025, at 4:30 p.m. ET. Q3 2025 Financial Highlights: Recor.
Owlet Reports Third Quarter 2025 Financial Results
Neutral
Business Wire
21 days ago
Owlet Partners with Rhapsody to Connect Remote Baby Monitoring Data to EHRs
LEHI, Utah--(BUSINESS WIRE)---- $owlt #babymonitor--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announces a partnership with Rhapsody, a global leader in digital health enablement and interoperability, to securely connect infant health insights from Owlet's FDA-cleared, prescription pulse oximeter, BabySat®, directly into their existing electronic health record (EHR) workflows. The integration creates a secure, standards-based pathway for Owlet's pediatric data t.
Owlet Partners with Rhapsody to Connect Remote Baby Monitoring Data to EHRs
Neutral
Business Wire
1 month ago
Owlet to Report Third Quarter 2025 Financial Results on November 13, 2025
LEHI, Utah--(BUSINESS WIRE)---- $owlt #babymonitor--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, plans to announce third quarter 2025 financial results after market close on Thursday, November 13, 2025. Owlet's President and Chief Executive Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call at 4:30 p.m. ET the same day to discuss these results and provide a business update. Participants may access the call at 833-47.
Owlet to Report Third Quarter 2025 Financial Results on November 13, 2025
Neutral
GlobeNewsWire
1 month ago
Kessler Topaz Meltzer & Check, LLP and Pomerantz LLP Announce Proposed Class Action Settlements on Behalf of Owners of Sandbridge Acquisition Corporation Common Stock and/or Purchasers of Owlet, Inc. Common Stock and/or Warrants – SBG SBG.WS SBG.U OWLT OWLTW
LOS ANGELES, CA, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Kessler Topaz Meltzer & Check, LLP and Pomerantz LLP announce proposed class action settlements on behalf of owners of Sandbridge Acquisition Corporation Common Stock and/or purchasers of Owlet, Inc. Common Stock and/or Warrants (NYSE: SBG) (NYSE: SBG.WS) (NYSE: SBG.U) (NYSE: OWLT) (OTC: OWLTW):
Kessler Topaz Meltzer & Check, LLP and Pomerantz LLP Announce Proposed Class Action Settlements on Behalf of Owners of Sandbridge Acquisition Corporation Common Stock and/or Purchasers of Owlet, Inc. Common Stock and/or Warrants – SBG SBG.WS SBG.U OWLT OWLTW
Positive
Zacks Investment Research
1 month ago
Owlet (OWLT) Surges 17.9%: Is This an Indication of Further Gains?
Owlet (OWLT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Owlet (OWLT) Surges 17.9%: Is This an Indication of Further Gains?